| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 6.65M | $21.15M | - | |
| Dir | 4.52M | $14.38M | - | |
| CEO | 2.26M | $7.19M | - | |
| Dir | 1.24M | $3.95M | - | |
| Other | 1.11M | $3.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $6.22 | $71,149.97 | -0.2% | +9.7% | -17.3% | |
| Sep 26, 2024 | Marriott Tina73 | President And COO | Sale+OE | 6,000 | $7.00 | $42,004.80 | -1.1% | +6.8% | -34.2% | |
| Sep 17, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $6.84 | $78,332.97 | -0.2% | +10.1% | -30.3% | |
| Sep 11, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE | 30,000 | $6.24 | $187,228.50 | -1.1% | +15.7% | -24.8% | |
| Sep 5, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell | 40,000 | $6.09 | $243,600.00 | -2.6% | +15.6% | -25.3% | |
| Sep 3, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $6.27 | $71,717.74 | -0.2% | +24.9% | -23.7% | |
| Aug 29, 2024 | Marriott Tina73 | President And COO | Sale+OE | 6,000 | $7.56 | $45,376.20 | -1.1% | -13.9% | -36.6% | |
| Aug 20, 2024 | Borgeson Blake69 | Director | Sell | 11,447 | $7.12 | $81,532.40 | -0.2% | -14.8% | -33.4% | |
| Aug 14, 2024 | Secora Michael74 | Chief Financial Officer | Sale+OE | 30,000 | $6.35 | $190,434.00 | -1.1% | +20.7% | -10.2% | |
| Aug 8, 2024 | Gibson Christopher70 | Chief Executive Officer | Sell | 50,000 | $6.86 | $343,000.00 | -3.2% | +5.0% | -19.3% |